Monday - February 23, 2026
New HHS petition Calls on the Trump Administration to Authorize Affordable Generic GLP-1 Drugs for Americans
February 12, 2026
WASHINGTON, Feb. 12 [Category: Political] -- Public Citizen issued the following news release:

* * *

New HHS petition Calls on the Trump Administration to Authorize Affordable Generic GLP-1 Drugs for Americans

*

WASHINGTON, D.C. -Today, Public Citizen filed a petition requesting that the United States Department of Health and Human Services (HHS) authorize generic competition for Novo Nordisk's semaglutide and Eli Lilly's tirzepatide, . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products